[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586939":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":15,"centralContacts":19,"locations":25,"responsibleParty":42,"collaborators":7,"id":44,"slug":7,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":52,"minAge":53,"maxAge":7,"enrollmentInfo":54,"targetDuration":7,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":7,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Abbott Diabetes Care","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DEVICE","FreeStyle Libre 3","Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)",[14],"FreeStyle Libre 3 Monitoring System",[16],{"name":17,"affiliation":5,"role":18},"Shridhara Karinka, PhD","STUDY_CHAIR",[20],{"name":21,"role":22,"phone":23,"phoneExt":7,"email":24},"MOHAMED NADA, PhD","CONTACT","5107495416","adc.clinical@abbott.com",[26],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Diabetes and Obesity Care","RECRUITING","Bend","Oregon","97702","United States",{"type":34,"coordinates":35},"Point",[36,37],-121.31531,44.05817,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":7,"phoneExt":7,"email":7},"Eden Miller, D.O.",{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100586939",false,"NCT06921902","Glycemic Metrics and Patterns in People With and Without Prediabetes","Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)","PREMAP","Inclusion Criteria:\n\n* Subject must be at least 18 years of age.\n* Subject must be willing and able to provide written signed and dated informed consent.\n\nExclusion Criteria:\n\n* Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.\n* Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.\n* Subject is known to be pregnant at the time of enrollment.\n* Subject has known allergy to medical grade adhesive, isopropyl alcohol and\u002For ethyl alcohol used to disinfect skin.\n* Subject is currently on any form of treatment indicated for the treatment of diabetes.\n* Subject is currently on any form of medication indicated for weight loss.",true,"ALL","18 Years",{"count":55,"type":56},2000,"ESTIMATED","OBSERVATIONAL","The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.",[60],"Pre Diabetes","2026-04-06",{"date":63,"type":64},"2026-04-09","ACTUAL",{"date":66,"type":64},"2025-02-28",{"date":68,"type":56},"2026-12",{"name":5,"class":6},1]